Search
-
Healthcare vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
GLP-1s are more than just weight loss drugs. They're a chance to rewrite our evolutionary story, to take control of our biology in a way never before possible.
-
Ipsos wins its seventh MSPA Americas Shoppers’ Choice Award
With stellar community feedback, iShopFor Ipsos is recognized for the seventh consecutive year
-
Does Everything Really Cause Cancer?
How our changing world is impacting our cells, and what it means for all of us.
-
Ipsos Pride Survey 2025: Majority are for anti-discrimination protections, but support slips for several LGBT+ issues
A new Ipsos survey across 26 countries finds the proportion in favour of everything from trans athletes to Pride Month marketing is down since 2021.
-
Our views on gender are consistent, but are we less willing to talk about it?
By and large, Americans' views on gender haven’t changed in the last two years, according to the Ipsos Consumer Tracker — except when it comes to having conversations about gender equality.
-
Despite overall uncertainty, we are somewhat confident in spending
Despite the uncertainty we've seen in various consumer indexes, many Americans remain confident about investing, taking out loans or buying a new home, according to the Ipsos Consumer Tracker.
-
If AI use at work is growing, we don't know it.
Workplaces are using AI at the same rates they were a year ago, according to the Ipsos Consumer Tracker.
-
Americans think student loans should be prioritized, simplified
58% of Americans with student loan debt say that it makes it hard to pay the bills each month, according to the Ipsos Consumer Tracker.
-
Mid-Year Oncology Review 2025: History Informs the Future
What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.
-
Is the system is still broken?
Below are five charts on where populist sentiment stands across 31 countries